A study found that T cells co‐expressing IL‐13Rα2‐CARs and HER2 showed improved tumor control in a human glioblastoma multiforme (GBM) orthotopic xenograft model (Hegde et al, 2013). The gene discussed is ERBB2; the disease is glioblastoma.